Facilitating the Development and Manufacturing of High-Quality Biologics for the Emerging Nordics Market
The 5th Biologics World Nordics 2024 event will bring together biologic and biosimilar developers and manufacturers, technology providers, CMOs and CROs from the Nordics region and beyond to explore partnership and technical collaboration opportunities, discuss best R&D and biomanufacturing practises, and debate growth strategies as Nordics developed biologics enter critical clinical phase II and III development stages.This is the only biologics market place in the Nordics area that demonstrates the region's enormous possibilities and provides a full network for Nordic biologic firms wishing to license/partner with large pharma, CROs, and CDMO/CMOs.
The Nordics region is playing a critical role in expanding medical knowledge and opening the path for revolutionary medicines that hold promise for patients globally. Explore the exciting progress of clinical studies on biologics and cell and gene therapy products from the Nordics biopharma.
High-throughput cell line creation and cell culture have considerably sped the discovery and development of novel biologics, improving the efficiency and scalability of biopharmaceutical manufacturing. Know-how on the latest development of cell line development and cell culture technologies have evolved and potentially changed the biologics drug manufacturing process to be more economically feasible.
Cost optimisation strategies coupled with the utilisation of advanced purification platforms have become essential for the biopharmaceutical industry, enabling efficient and economical production of high-quality therapeutics. Immerse into the most focused biologics downstream processing with the ultimate goal of meeting quality and purity requirements of biologics drug products at lower cost.
Listen from the Nordic region which demonstrated exceptional process in commercialising its R&D objectives, capitalising on its strong innovation ecosystem, supportive regulatory framework, and strategic alliances to translate cutting-edge research into marketable products and solutions.
The Nordic biologics sector is poised to drive transformative advances in medicine, create new market opportunities, and address unmet medical needs on a global scale by leveraging the region’s expertise in biologics R&D and manufacturing, cutting-edge research capabilities, and collaborative approach to healthcare innovation.
Limited Super (By 31st Oct 2023)
£ 1,050
Limited Special (By 30th Nov 2023)
£ 1,250
Early Bird (By 2nd Feb 2024)
£ 1,450
Standard Price
£ 1,650
Limited Group Packages
Limited Super (By 31st Oct 2023)
£ 2,250
Limited Special (By 30th Nov 2023)
£ 2,450
Early Bird (By 2nd Feb 2024)
£ 2,650
Standard Price
£ 2,850
Group Discount for Solution Providers & General Public:
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off
This conference was long overdue in Singapore and critical to making sure that CCT understands current challenges facing our Asian based clients. This allows us to quickly provide new or turn-key solutions and products that meet their needs.
Cold Chain Technologies
BMA was an excellently organised event and as a sponsor, participating was very valuable in meeting new connections and engaging with existing customers & contacts. I would recommend anyone involved in the regional biologics industry to participate in the event.
MasterControl
With the many restrictions and the need to hold the event onsite and online, I do think this event is well planned and held. Easy registration. Spacious, simple and professional settings. All the staffs are very friendly and helpful too. Thank you!
West Pharmaceutical Services
Bioworkshops appreciate the effort IMAPAC invested to restore a strong In-person participation to this hybrid event, bringing together many of the biologics manufacturing leaders from Asia along and global experts.
Bioworkshops Limited
The conference was a great success and fruitful.
Biocon
Fantastic conference with professional team.
Blue Blood Biotech
Informative session. Exhibition was well targeted and diverse. Presenters shared latest development
Hilman Laboratories
It was an awesome experience to interact with so many energetic young professionals around the globe and share technical information. I want to express my heartfelt gratitude to the organizer for such a great event!
Incepta
It was great to attend the session physically, and have some exchange with industry players and exchange ideas. Thanks IMAPAC for great organisation!
EVF Project Process Manufacturing Leader
Great forum for face to face interactions and for exchange of ideas and information.
WuXi Biologics
The entire event was managed flawlessly by the Organizers. I personally did not face any technical glitches despite this even was organized in a hybrid manner. Almost every speaker gave a high quality presentation which was very insightful.
Lupin Ltd
It was really great experience for me to be associated with IMAPAC which organizes high standard conference. Speakers from various domains/fields are thoughtfully chosen & they have delivered the relevant fields of present post-covid pandemic biologics scenario.
Serum Institute Of India Pvt. Limited
A well organized ambitious meeting. I hope it will continue to develop in the future.
GSK Vaccines
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2023 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
